At Mammotome, our expertise and compassion for breast care makes us the indispensable partner to physicians, clinicians and patients. Our drive for innovation is rivaled only by our compassion for the people we serve, from the clinicians and surgeons who demand consistently precise solutions, to the patients and families seeking peace of mind. We boast a comprehensive range of products that create better outcomes in breast care and provide physicians, clinicians and patients with educational resources that guide their journey. Our extensive product portfolio includes Mammotome® breast biopsy devices, specimen radiograph system and tissue markers; distribution of Kubtec’s XPERT® 40 Specimen Radiography System and the Neoprobe® Gamma Detection System. For more information, please visit mammotome.com. The Mammotome brand of products is sold in over 50 different countries throughout the world. Headquartered in Cincinnati, OH, Mammotome has been part of the Danaher Corporation since 2014.

Most deadly diseases can be cured through early diagnosis with stroke being a prime example. Advanced point-of-care diagnostics are essential. MRI and CT scan are limited but ultrasound presents a remarkable opportunity due to its safety and accessibility. Resolve Stroke develops groundbreaking software engines, capable of decoding 100% of raw ultrasound data—compared to the 10% utilized by current technology. With the ambition of reproducing the power of ultrasound in cardiological applications, our first engine, now integrated into an ultrasound cart, enables bedside neuromonitoring, promising to save millions of lives. We are just beginning to understand the impact of our innovations.

SuperSonic Imagine conçoit, fabrique et commercialise une plateforme échographique dont la technologie exclusive ultrarapide, UltraFast, a donné naissance à de nouveaux modes d’imagerie, aujourd’hui devenus des standards dans le parcours de soins non-invasifs pour la caractérisation des maladies du sein, du foie ou de la prostate. Le premier mode innovant UltraFast est l’élastographie ShearWave™ (SWE), qui permet aux médecins de visualiser et d’analyser instantanément la dureté des tissus, information capitale pour le diagnostic de nombreuses pathologies. À ce jour, plus de 1000 publications valident les bénéfices de ses technologies. SuperSonic MACH 30 introduit une nouvelle génération d’imagerie UltraFast permettant l’optimisation de l’ensemble des modes d’imagerie innovants : ShearWave PLUS, Doppler UltraFast, Angio PLUS, TriVu et Needle PLUS. Avec plus de 3000 échographes installés dans le monde, SuperSonic Imagine est présente dans plus de 100 pays.